✦ LIBER ✦
9318 POSTER Phase 3 Randomized Study of Ipilimumab (IPI) Plus Dacarbazine (DTIC) Vs DTIC Alone as First Line Treatment in Patients With Unresectable Stage III or IV Melanoma
✍ Scribed by Robert, C.; Thomas, L.; Garbe, C.; Lebbe, C.; Baurain, J.F.; Testori, A.; Maio, M.; Chen, T.; Hoos, A.; Wolchok, J.
- Book ID
- 123104693
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 59 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.